ROC analysis for TMSB10 expression and glioma grade showed that the AUC was 0.929 (Fig. 6B), suggesting that TMSB10 has the potential to serve as a biomarker for predicting glioma grade. Here, TMSB10 is linked to central nervous system cancer.